37 research outputs found
Quantitative High-Throughput Screen Identifies Inhibitors of the Schistosoma mansoni Redox Cascade
Schistosomiasis is a tropical disease associated with high morbidity and mortality, currently affecting over 200 million people worldwide. Praziquantel is the only drug used to treat the disease, and with its increased use the probability of developing drug resistance has grown significantly. The Schistosoma parasites can survive for up to decades in the human host due in part to a unique set of antioxidant enzymes that continuously degrade the reactive oxygen species produced by the host's innate immune response. Two principal components of this defense system have been recently identified in S. mansoni as thioredoxin/glutathione reductase (TGR) and peroxiredoxin (Prx) and as such these enzymes present attractive new targets for anti-schistosomiasis drug development. Inhibition of TGR/Prx activity was screened in a dual-enzyme format with reducing equivalents being transferred from NADPH to glutathione via a TGR-catalyzed reaction and then to hydrogen peroxide via a Prx-catalyzed step. A fully automated quantitative high-throughput (qHTS) experiment was performed against a collection of 71,028 compounds tested as 7- to 15-point concentration series at 5 µL reaction volume in 1536-well plate format. In order to generate a robust data set and to minimize the effect of compound autofluorescence, apparent reaction rates derived from a kinetic read were utilized instead of end-point measurements. Actives identified from the screen, along with previously untested analogues, were subjected to confirmatory experiments using the screening assay and subsequently against the individual targets in secondary assays. Several novel active series were identified which inhibited TGR at a range of potencies, with IC50s ranging from micromolar to the assay response limit (∼25 nM). This is, to our knowledge, the first report of a large-scale HTS to identify lead compounds for a helminthic disease, and provides a paradigm that can be used to jump-start development of novel therapeutics for other neglected tropical diseases
Interactions between Natural Populations of Human and Rodent Schistosomes in the Lake Victoria Region of Kenya: A Molecular Epidemiological Approach
One of the world's most prevalent neglected diseases is schistosomiasis, which infects approximately 200 million people worldwide. Schistosoma mansoni is transmitted to humans by skin penetration by free-living larvae that develop in freshwater snails. The origin of this species is East Africa, where it coexists with its sister species, S. rodhaini. Interactions between these species potentially influence their epidemiology, ecology, and evolutionary biology, because they infect the same species of hosts and can hybridize. Over two years, we examined their distribution in Kenya to determine their degree of overlap geographically, within snail hosts, and in the water column as infective stages. Both species were spatially and temporally patchy, although S. mansoni was eight times more common than S. rodhaini. Both species overlap in the time of day they were present in the water column, which increases the potential for the species to coinfect the same host and interbreed. Peak infective time for S. mansoni was midday and dawn and dusk for S. rodhaini. Three snails were coinfected, which was more common than expected by chance. These findings indicate a lack of obvious isolating mechanisms to prevent hybridization, raising the intriguing question of how the two species retain separate identities
Whole genome analysis of a schistosomiasis-transmitting freshwater snail
Biomphalaria snails are instrumental in transmission of the human blood fluke Schistosoma mansoni. With the World Health Organization's goal to eliminate schistosomiasis as a global health problem by 2025, there is now renewed emphasis on snail control. Here, we characterize the genome of Biomphalaria glabrata, a lophotrochozoan protostome, and provide timely and important information on snail biology. We describe aspects of phero-perception, stress responses, immune function and regulation of gene expression that support the persistence of B. glabrata in the field and may define this species as a suitable snail host for S. mansoni. We identify several potential targets for developing novel control measures aimed at reducing snail-mediated transmission of schistosomiasis
Natural and human induced factors influencing the abundance of Schistosoma host snails in Zambia
Corrigendum: Whole genome analysis of a schistosomiasis-transmitting freshwater snail
This corrects the article DOI: 10.1038/ncomms15451
Schistosoma mansoni among pre-school children in Musozi village, Ukerewe Island, North-Western-Tanzania: prevalence and associated risk factors
The Association of Falciparum Malaria and HIV/AIDS Infection in Relation to Parasitaemia and Anti- Malarial Treatment Outcome as seen at the Moi Teaching and Referral Hospital in Eldoret, Kenya
This paper examines the effect of HIV infection on falciparum malaria parasitaemia based on a study conducted at the Moi Teaching and Referral Hospital in Eldoret, Kenya. One hundred consenting patients with malaria were recruited into the study, malaria parasitaemia levels, HIV status and CD4 counts were determined for each patient, and the outcome of antimalarial drug treatment with quinine or artemisinin derivative drugs observed. Malaria parasitaemia was monitored for each patient after antimalarial drug administration, for up to 7 days. Of the 100 patients recruited with falciparum malaria, 60% were children (<18 years) and 40% were adults. Of the total admitted subjects to study, 17% (5 children and 12 adults) were HIV positive. Malaria parasitaemia levels were higher in HIV positive patients than in HIV negative individuals.and that HIV-negative individuals had a better parasitaemia clearance outcome by day seven (pday7) compared to HIV-positive ones whose parasitaemia clearance went beyond seven-day treatment period. This study strongly recommends investigative work to be done in view of the recent Kenya Government launch of ACT as a first line course of treatment for uncomplicated malaria